Adamantinoma-like Ewing Sarcoma of the Salivary Glands: A Newly Recognized Mimicker of Basaloid Salivary Carcinomas

Adamantinoma-like Ewing sarcoma (ALES) is a rare tumor that demonstrates the EWSR1-FLI1 translocation characteristic of Ewing sarcoma despite overt epithelial differentiation including diffuse expression of cytokeratins and p40. Most cases of ALES described to date have occurred in the head and neck where they can mimic a wide range of small round blue cell tumors. Because distinguishing ALES from basaloid salivary gland carcinomas can be particularly difficult, we analyzed a series of 10 ALESs that occurred in the salivary glands with the aim of identifying features that allow for better recognition of this entity. The salivary ALESs included 8 parotid gland and 2 submandibular gland tumors in patients ranging from 32 to 77 years (mean: 52 y). Nine were initially misclassified as various epithelial neoplasms. Although these tumors displayed the basaloid cytology, rosette formation, infiltrative growth, and nuclear monotony characteristic of ALES, peripheral palisading and overt keratinization were relatively rare in this site. Salivary ALESs not only displayed positivity for AE1/AE3, p40, and CD99, but also demonstrated a higher proportion of synaptophysin reactivity than has been reported for nonsalivary ALESs. These morphologic and immunohistochemical findings make ALES susceptible to misclassification as various other tumors including basal cell adenocarcinoma, adenoid cystic carcinoma, squamous cell carcinoma, NUT carcinoma, large cell neuroendocrine carcinoma and myoepithelial carcinoma. Nevertheless, monotonous cytology despite highly infiltrative growth and concomitant positivity for p40 and synaptophysin can provide important clues for consideration of ALES, and identification of the defining EWSR1-FLI1 translocations can confirm the diagnosis.

[1]  C. Fisher,et al.  NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas , 2018, The American journal of surgical pathology.

[2]  R. Chernock,et al.  Proceedings of the NASHNP Companion Meeting, March 18th, 2018, Vancouver, BC, Canada: Salivary Neuroendocrine Carcinoma—An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin , 2018, Head and Neck Pathology.

[3]  J. Bishop,et al.  Adamantinoma‐like Ewing sarcoma of the parotid gland: Cytopathologic findings and differential diagnosis , 2018, Diagnostic cytopathology.

[4]  C. Antonescu,et al.  Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions , 2017, Nature Communications.

[5]  S. Shi,et al.  EWSR1 rearrangement is present in a subset of myoepithelial tumors of salivary glands with variable morphology and does not correlate with clinical behavior. , 2017, Annals of diagnostic pathology.

[6]  J. Bishop,et al.  Sinonasal adamantinoma-like Ewing sarcoma: A case report. , 2017, Pathology, research and practice.

[7]  L. Macconaill,et al.  Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. , 2017, Archives of pathology & laboratory medicine.

[8]  J. Bishop,et al.  Sinonasal Small Round Blue Cell Tumors: An Immunohistochemical Approach. , 2017, Surgical pathology clinics.

[9]  M. Sobrinho-Simões,et al.  EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE) , 2017, Virchows Archiv.

[10]  Marian Harris,et al.  Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.

[11]  R. Seethala,et al.  Comparison of p63 and p40 (&Dgr;Np63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[12]  C. Antonescu,et al.  Adamantinoma-like Ewing Family Tumors of the Head and Neck: A Pitfall in the Differential Diagnosis of Basaloid and Myoepithelial Carcinomas , 2015, The American journal of surgical pathology.

[13]  C. Antonescu,et al.  Adamantinoma-Like Ewing Sarcoma Mimicking Basal Cell Adenocarcinoma of the Parotid Gland: A Case Report and Review of the Literature , 2015, Head and Neck Pathology.

[14]  A. Agaimy,et al.  Clear Cell Myoepithelial Carcinoma of Salivary Glands Showing EWSR1 Rearrangement: Molecular Analysis of 94 Salivary Gland Carcinomas With Prominent Clear Cell Component , 2015, The American journal of surgical pathology.

[15]  M. Beckerle,et al.  EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma , 2015, Genes & cancer.

[16]  J. Bishop,et al.  Polymorphous Low Grade Adenocarcinoma has a Consistent p63+/p40− Immunophenotype that Helps Distinguish it from Adenoid Cystic Carcinoma and Cellular Pleomorphic Adenoma , 2015, Head and Neck Pathology.

[17]  T. Kasai,et al.  The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma , 2014, Virchows Archiv.

[18]  M. Sobrinho-Simões,et al.  Carcinoma of the Thyroid With Ewing Family Tumor Elements and Favorable Prognosis , 2014, International journal of surgical pathology.

[19]  C. Antonescu,et al.  Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours , 2014, Pathology.

[20]  M. Sobrinho-Simões,et al.  PNET with neuroendocrine differentiation of the lung , 2013, International journal of surgical pathology.

[21]  Mio Tanaka,et al.  Adamantinoma-like Ewing family tumor of soft tissue associated with the vagus nerve: a case report and review of the literature. , 2013, The American journal of surgical pathology.

[22]  C. Antonescu,et al.  EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland , 2011, Genes, chromosomes & cancer.

[23]  M. Sobrinho-Simões,et al.  Small-Cell (Basaloid) Thyroid Carcinoma , 2011, International journal of surgical pathology.

[24]  K. Lucas,et al.  Current Therapeutic Approaches in Metastatic and Recurrent Ewing Sarcoma , 2010, Sarcoma.

[25]  B. Perez-Ordonez,et al.  Primary Extraskeletal Ewing Family Tumor With Complex Epithelial Differentiation: A Unique Case Arising in the Lateral Neck Presenting With Horner Syndrome , 2008, The American journal of surgical pathology.

[26]  Y. Takakura,et al.  Adamantinoma-like Ewing’s sarcoma with EWS-FLI1 fusion gene: a case report , 2006, Virchows Archiv.

[27]  T. Golub,et al.  Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. , 2006, Cancer cell.

[28]  J. Goldblum,et al.  Morphologic and Immunophenotypic Diversity in Ewing Family Tumors: A Study of 66 Genetically Confirmed Cases , 2005, The American journal of surgical pathology.

[29]  A. Pappo,et al.  Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. , 2003, Medical and pediatric oncology.

[30]  S. Donaldson,et al.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. , 2003, The New England journal of medicine.

[31]  H. Dorfman,et al.  Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. , 1999, The American journal of surgical pathology.

[32]  Jerad M. Gardner,et al.  Ewing sarcoma. , 2014, Seminars in diagnostic pathology.